Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
American Journal of Clinical Dermatology
Published in: American Journal of Clinical Dermatology 6/2015

01-12-2015 | Original Research Article

Effects of Helicobacter pylori Eradication in Chronic Spontaneous Urticaria: Results from a Retrospective Cohort Study

Authors: Harald-Morten Curth, Johanna Dinter, Kerstin Nigemeier, Fabian Kütting, Nicolas Hunzelmann, Hans-Michael Steffen

Published in: American Journal of Clinical Dermatology | Issue 6/2015

Login to get access

Abstract

Background and Objective

Helicobacter pylori (Hp) infection has been hypothesised to play a major role in the pathogenesis of chronic spontaneous urticaria (CSU). Despite only weak evidence from Hp eradication studies, screening for Hp infection is still recommended in several CSU guidelines. The aim of this study was to investigate the effect of Hp eradication in combination with standard CSU treatment in Hp-positive compared with Hp-negative patients, applying the latest guidelines for both diseases.

Methods

138 consecutive patients with CSU were enrolled in this retrospective cohort study. All patients underwent gastroscopy and Hp status was determined by urease testing and histologic examination. Seventy-five patients were diagnosed as Hp negative and 47 patients fulfilled criteria for definite Hp infection, 45 of whom received eradication therapy. Sixteen patients who received eradication therapy without an appropriate indication served as the medication control. All patients received symptomatic treatment with antihistamines and/or glucocorticoids regardless of Hp status. Partial response (PR) was defined as subjective amelioration of CSU symptoms; patients returning for further CSU treatment within 6 months were considered non-responders/relapsers (NRs).

Results

The prevalence of Hp infection was comparable with Hp seroprevalence data reported for healthy western populations. Standard treatment of CSU led to relief of symptoms independent of Hp status. Hp eradication by standard triple therapy had no additional effect on PR (p = 0.32) or NR (p = 0.50).

Conclusions

Hp eradication has no discernible effect on CSU beyond that of standard CSU therapy. Therefore, Hp eradication should only be initiated in accordance with currently accepted indications of Hp treatment guidelines.
Literature
1.
2.
Maurer M, Bindslev-Jensen C, Gimenez-Arnau A, Godse K, Grattan CE, Hide M, et al. Chronic idiopathic urticaria (CIU) is no longer idiopathic: time for an update [letter]. Br J Dermatol. 2013;168(2):455–6.CrossRefPubMed
3.
Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328(22):1599–604.CrossRefPubMed
4.
Kikuchi Y, Kaplan AP. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol. 2001;107(6):1056–62.CrossRefPubMed
5.
Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol. 1989;84(1):66–71.CrossRefPubMed
6.
Grattan CE, Wallington TB, Warin RP, Kennedy CT, Bradfield JW. A serological mediator in chronic idiopathic urticaria–a clinical, immunological and histological evaluation. Br J Dermatol. 1986;114(5):583–90.CrossRefPubMed
7.
Yamanishi S, Iizumi T, Watanabe E, Shimizu M, Kamiya S, Nagata K, et al. Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun. 2006;74(1):248–56.PubMedCentralCrossRefPubMed
8.
Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991;338(8776):1175–6.CrossRefPubMed
9.
Di Campli C, Gasbarrini A, Nucera E, Franceschi F, Ojetti V, Sanz TE, et al. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci. 1998;43(6):1226–9.CrossRefPubMed
10.
Wedi B, Wagner S, Werfel T, Manns MP, Kapp A. Prevalence of Helicobacter pylori-associated gastritis in chronic urticaria. Int Arch Allergy Immunol. 1998;116(4):288–94.CrossRefPubMed
11.
Magen E, Mishal J, Schlesinger M, Scharf S. Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test. Helicobacter. 2007;12(5):567–71.CrossRefPubMed
12.
Ojetti V, Armuzzi A, De Luca A, Nucera E, Franceschi F, Candelli M, et al. Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria. Int Arch Allergy Immunol. 2001;125(1):66–72.CrossRefPubMed
13.
Yadav MK, Rishi JP, Nijawan S. Chronic urticaria and Helicobacter pylori. Indian J Med Sci. 2008;62(4):157–62.CrossRefPubMed
14.
Maurer M, Magerl M, Metz M, Zuberbier T. Revisions to the international guidelines on the diagnosis and therapy of chronic urticaria. J Dtsch Dermatol Ges. 2013;11(10):971–8.CrossRefPubMed
15.
Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, European Academy of Allergy and Clinical Immunology, Global Allergy and Asthma European Network, European Dermatology Forum, World Allergy Organization, et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014;69(7):868–87.CrossRefPubMed
16.
Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CE. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy. 2009;64(9):1256–68.CrossRefPubMed
17.
Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection–the Maastricht IV/Florence Consensus Report. Gut. 2012;61(5):646–64.CrossRefPubMed
18.
Fischbach W, Malfertheiner P, Hoffmann JC, Bolten W, Bornschein J, Gotze O, et al. S3-guideline “Helicobacter pylori and gastroduodenal ulcer disease” [in German]. Z Gastroenterol. 2009;47(1):68–102.CrossRefPubMed
19.
Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000;181(4):1359–63.CrossRefPubMed
20.
Federman DG, Kirsner RS, Moriarty JP, Concato J. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol. 2003;49(5):861–4.CrossRefPubMed
21.
Fukuda S, Shimoyama T, Umegaki N, Mikami T, Nakano H, Munakata A. Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. J Gastroenterol. 2004;39(9):827–30.CrossRefPubMed
22.
Gaig P, Garcia-Ortega P, Enrique E, Papo M, Quer JC, Richard C. Efficacy of the eradication of Helicobacter pylori infection in patients with chronic urticaria. A placebo-controlled double blind study. Allergol Immunopathol (Madr). 2002;30(5):255–258.
23.
Giamarellos-Bourboulis EJ. Immunomodulatory therapies for sepsis: unexpected effects with macrolides. Int J Antimicrob Agents. 2008;32(Suppl 1):S39–43.CrossRefPubMed
24.
Zuberbier T, Asero R, Bindslev-Jensen C, Walter CG, Church MK, Gimenez-Arnau A, et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy. 2009;64(10):1417–26.CrossRefPubMed
25.
Greaves MW, Tan KT. Chronic urticaria: recent advances. Clin Rev Allergy Immunol. 2007;33(1–2):134–43.CrossRefPubMed
26.
Bakos N, Fekete B, Prohaszka Z, Fust G, Kalabay L. High prevalence of IgG and IgA antibodies to 19-kDa Helicobacter pylori-associated lipoprotein in chronic urticaria. Allergy. 2003;58(7):663–7.CrossRefPubMed
27.
Amedei A, Bergman MP, Appelmelk BJ, Azzurri A, Benagiano M, Tamburini C, et al. Molecular mimicry between Helicobacter pylori antigens and H+, K+–adenosine triphosphatase in human gastric autoimmunity. J Exp Med. 2003;198(8):1147–56.PubMedCentralCrossRefPubMed
28.
Schnyder B, Helbling A, Pichler WJ. Chronic idiopathic urticaria: natural course and association with Helicobacter pylori infection. Int Arch Allergy Immunol. 1999;119(1):60–3.CrossRefPubMed
29.
Erel F, Sener O, Erdil A, Karaayvaz M, Gur G, Caliskaner Z, et al. Impact of Helicobacter pylori and Giardia lamblia infections on chronic urticaria. J Investig Allergol Clin Immunol. 2000;10(2):94–7.PubMed
30.
Dauden E, Jimenez-Alonso I, Garcia-Diez A. Helicobacter pylori and idiopathic chronic urticaria. Int J Dermatol. 2000;39(6):446–52.CrossRefPubMed
31.
Hellmig S, Troch K, Ott SJ, Schwarz T, Folsch UR. Role of Helicobacter pylori infection in the treatment and outcome of chronic urticaria. Helicobacter. 2008;13(5):341–5.CrossRefPubMed
32.
Valsecchi R, Pigatto P. Chronic urticaria and Helicobacter pylori. Acta Derm Venereol. 1998;78(6):440–2.CrossRefPubMed
33.
Wustlich S, Brehler R, Luger TA, Pohle T, Domschke W, Foerster E. Helicobacter pylori as a possible bacterial focus of chronic urticaria. Dermatology. 1999;198(2):130–2.CrossRefPubMed
34.
Shakouri A, Compalati E, Lang DM, Khan DA. Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation system. Curr Opin Allergy Clin Immunol. 2010;10(4):362–9.PubMed
35.
Magen E, Schlesinger M, Hadari I. Chronic urticaria can be triggered by eradication of Helicobacter pylori. Helicobacter. 2013;18(1):83–7.CrossRefPubMed
36.
Selgrad M, Meissle J, Bornschein J, Kandulski A, Langner C, Varbanova M, et al. Antibiotic susceptibility of Helicobacter pylori in central Germany and its relationship with the number of eradication therapies. Eur J Gastroenterol Hepatol. 2013;25(11):1257–60.CrossRefPubMed
Metadata
Title
Effects of Helicobacter pylori Eradication in Chronic Spontaneous Urticaria: Results from a Retrospective Cohort Study
Authors
Harald-Morten Curth
Johanna Dinter
Kerstin Nigemeier
Fabian Kütting
Nicolas Hunzelmann
Hans-Michael Steffen
Publication date
01-12-2015
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 6/2015
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.1007/s40257-015-0152-6

Other articles of this Issue 6/2015

American Journal of Clinical Dermatology 6/2015 Go to the issue

Review Article

Prurigo Pigmentosa: Literature Review

Original Research Article

Quality of Life and Gastrointestinal Symptoms in Long-Term Treated Dermatitis Herpetiformis Patients: A Cross-Sectional Study in Finland

Review Article

Alternative Systemic Treatments for Vitiligo: A Review

Review Article

The Safety and Efficacy of Narrow Band Ultraviolet B Treatment in Dermatology: A Review

Review Article

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: An Update

Review Article

Granular Parakeratosis: A Comprehensive Review and a Critical Reappraisal